Legislative Observatory
European Parliament
Please fill in this field to find a procedure

2006 discharge: European Monitoring Centre for Drugs and Drug Addiction EMCDDA

2007/2050(DEC)

PURPOSE: presentation of the final accounts of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) for the 2006 financial year.

CONTENT: this document sets out a detailed account of the implementation of the EMCDDA’s 2006 budget. It indicates that EMCDDA’s final budget amounted to 13.12 million EUR in 2006 (compared with 12.8 million EUR in 2005) 92% of which is derived from a Community subsidy.

In terms of personnel, the EMCDDA, whose headquarters are in Lisbon (Portugal) had 77 posts in its establishment plan 68 of which are occupied and 23 others (auxiliary contracts, contract staff and temporary replacements) amounting to 91 posts undertaking operational, administrative or mixed tasks. Expenditure on personnel in 2006 represented 6.373 million EUR.

The main task of the EMCDDA is to provide the Union and its Member States with information regarding illegal drugs in the Union and their effects on Europeans.  In particular, it collects data, carries out surveys, disseminates information, improves the coordination between national and Community actions in this field and promotes the integration of information on drugs in international programmes.

In 2006, the EMCDDA’s activities mainly focused on:

The REITOX network: the Observatory manages a computerised network for the collection and exchange of information called Reitox (the European Information Network on Drugs and Drug Addiction); this network links together the national drugs information networks, specialised centres in Member States and the information systems of international organisations cooperating with the Observatory.

Publications:

  • Annual Report on the state of the drugs problem in Europe (23 language versions, publication and interactive website web),
  • Annual report ‘Selected issues’ (EN, publication and interactive website),
  • Statistical bulletin and interactive website including more than 250 tables, 150 illustrations and PDF files,
  • General activity report (annual, EN),
  • ‘Drugnet Europe’ newsletter (4 issues - 2 in five languages, 2 in English),
  • Studies/technical and scientific articles (21),
  • Scientific articles and summaries (16);
  • Other websites: creation/updating/development of content:
  • Country situation summaries;
  • Country data profiles;
  • Drug treatment overviews;
  • European legal database on drugs;
  • Evaluation instruments bank;
  • Exchange on drug demand reduction action;
  • Promotional brochures: 4 prepared ;
  • Media products: 174 products of various kinds;
  • Participation in 162 international conferences/meetings ;
  • Organisation of 27 technical and scientific meetings.

The Observatory’s full accounts are available from the following address:

http://www.emcdda.europa.eu/index.cfm?fuseaction=public.Content&nnodeid=6465&sLanguageiso=EN